Open Call ICT-14-2016-2017: Big Data PPP: Cross-Sectorial and Cross-Lingual Data Integration and Experimentation

European CommissionEurope lacks a systematic transfer of knowledge and technology across different sectors and there is an underdeveloped data sharing and linking culture. Traditionally, data has been collected and used for a certain purpose within sectorial "silos", while using data across sectors for offering new services opens new opportunities for solving business and societal challenges. The lack of agreed standards and formats, and the low rates of publishing data assets in machine discoverable formats further hold back data integration. The fact that textual data appears in many languages creates an additional challenge for sharing and linking such data. Finally, there is a lack in Europe of secure environments where researchers and SMEs can test innovative services and product ideas based on open data and business data.

The challenge is to break these barriers and to foster exchange, linking and re-use, as well as to integrate data assets from multiple sectors and across languages and formats. A more specific challenge is to create a stimulating, encouraging and safe environment for experiments where not only data assets but also knowledge and technologies can be shared.

Proposals should cover one of the following bullets:

  • a. Data integration activities will address data challenges in cross-domain setups, where similar contributions of data assets will be required by groups of EU industries that are arranged along data value chains (i.e. such that the value extracted by a company in a given industrial sector is greatly increased by the availability and reuse of data produced by other companies in different industrial sectors). The actions will cover the range from informal collaboration to formal specification of standards and will include (but not be limited to) the operation of shared systems of entity identifiers (so that data about the same entity could be easily assembled from different sources), the definition of agreed data models (so that two companies carrying out the same basic activity would produce data organised in the same way, to the benefit of developers of data analytics tools), support for multilingual data management, data brokerage schemes and the definition of agreed processes to ensure data quality and the protection of commercial confidentiality and personal data. The actions are encouraged to make use of existing data infrastructures and platforms.
  • b. Data experimentation incubators should address big data experimentation in a cross-sectorial, cross lingual and/or cross-border setup. This setup should include access to data in different domains and languages, appropriate computational infrastructure, and open software tools. The incubator should make these available to the experimenters, who are expected to be mainly SMEs, web entrepreneurs and start-ups. Experimentation is to be conducted on horizontal/vertical contributed data pools provided by the incubator. At least half of the experiments should address challenges of industrial importance jointly defined by the data providers, where quantitative performance targets are defined beforehand and results measured against them. Effective cross-sector and cross-border exchange and re-use of data are key elements in the experiments ecosystem supported by the incubators. Therefore, the incubators are expected to address the technical, linguistic, legal, organisational, and IPR issues, and provide a supported environment for running the experiments. To remain flexible on which experiments are carried out and to allow for a fast turn-over of data experimentation activities, the action may involve financial support to third parties, in line with the conditions set out in part K of the General Annexes. The proposal will define the selection process of the experimenters running the data activities for which financial support will be granted (typically in the order of EUR 50 000 - 100 000[1] per party). At least 70% of the EU funding shall be allocated to this purpose. Experiments are expected to run for a maximum of 6 months, while the incubator should run for a minimum of three years. The proposals are expected to explain how the incubator would become self-sustaining by the end of the funded duration of action.

The Commission considers that proposals requesting a contribution from the EU of between EUR 1 and 3 million (for the data integration activities under a) or about EUR 7 million (for the incubators under b) would allow this area to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Deadline Date: 12 April 2016 17:00:00 (Brussels local time)

Type of action: IA Innovation action.

For topic conditions, documents and submission service, please visit:
http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/5093-ict-14-2016-2017.html

PS: Find your partners or consortia preparing a project proposal
If you are working on Horizon 2020 research project proposals and you would be interested in a SME partner from Germany, please contact us, we are ready to share our experience, expertise and knowledge. If you need help to identify a potential partner with particular competences, facilities or experience, please explore and join our project, (HEALTH IT) SPACE, at www.healthitspace.eu.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

To be Happier, Take a Vacation... from Y…

Today, nearly every American - 91% - owns a cellphone that can access the internet, according to the Pew Research Center. In 2011, only about one-third did. Another study finds...

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...